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Metabolomic analysis of Campylobacter jejuni by direct injection 
electrospray ionisation mass spectrometry 
!
Robert M. Howlett, Matthew P. Davey and David J. Kelly 
!
Summary 
Direct injection mass spectrometry (DIMS) is a means of rapidly obtaining 
metabolomic phenotype data in both prokaryotes and eukaryotes. Given our 
generally poor understanding of Campylobacter metabolism, the high- throughput 
and relatively simple sample preparation of DIMS has made this an attractive 
technique for metabolism-related studies and hypothesis generation, especially 
when attempting to analyse metabolic mutants with no clear phenotype. Here we 
describe a metabolomic fingerprinting approach with sampling and extraction 
methodologies optimised for direct-injection electrospray-ionisation mass 
spectrometry (ESI-MS), which we have used as a means of comparing wild-type 
and isogenic mutant strains of C. jejuni with various metabolic blocks. 
Key Words 
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!1. Introduction 
Metabolomics is an approach to understand cellular metabolic pathways, either at 
the level of individual pathways or a specific set of metabolites (targeted approach) 
or through an overall assessment of a cellÕs global metabolite content (non-
targeted approach). While methods aimed at identifying specific metabolites and 
analysing their cellular concentrations are not new, it has only recently been 
possible to analyse and process large numbers of metabolites simultaneously 
using high resolution nuclear magnetic resonance (NMR) or mass spectrometry 
(MS) based techniques. This has enabled methods to be developed for the 
preliminary analysis of Ôsilent mutationsÕ in genes involved in central and non-
central metabolic pathways, by comparing the global metabolite profiles of wild 
type versus mutated cells (1). 
Dunn et al. (2) noted the many techniques utilised for sampling the metabolome 
and at present no single technology dominates; each has its own biased 
metabolite detection and strengths for certain applications. Electrospray ionisation 
time of flight mass spectrometry (ESI-TOF-MS) is a technique that has been 
used for high throughput fingerprinting in both plants and bacteria (1, 2). Although 
ESI-TOF- MS based metabolomics can suffer from a lack of mass accuracy its 
high sensitivity and high throughput make it an ideal candidate for establishing a 
strategy for the initial analysis of a large number of cellular metabolites. Similar 
methodologies were originally utilised for high-throughput clinical screening, 
however there have now been several microbial applications of this technique. 
Initially used in bacterial strain discrimination (3, 4), Kaderbhai et al. (5) showed 
that direct injection ESI-TOF-MS techniques were capable of discriminating 
between tryptophan metabolism mutants in E. coli. Our recent work has shown that 
!putative metabolite allocation to ESI-TOF-MS outputs can enable visualisation of 
metabolic blocks in C. jejuni amino-acid metabolism mutants (1). ESI-TOF-MS 
techniques are advantageous over other techniques such as NMR when 
attempting a non- targeted analysis, due to their far higher sensitivity; however the 
absence of a chromatographic step makes unambiguous metabolite identification 
impossible. Li et al. (6), has since built on the DIMS fingerprinting techniques in 
(1) by separating and identifying the key metabolites of antibiotic resistant mutants 
of C. jejuni using UHPLC-MS. For this reason it is important that DIMS 
techniques are used as a Ôfirst stepÕ for hypothesis formation towards the 
function of putative metabolic genes before rigorous metabolite identification or 
phenotypic analysis is performed. The potential for analysing altered metabolic 
fluxes as organisms experience different conditions, such as changes to 
temperature or growth phase, also exists (7). 
Quenching of metabolism and metabolite extraction are areas of intense debate 
and concern in metabolomics, as many metabolite pools turn-over on a time scale 
of the same order (or shorter) as the time taken to quench metabolic reactions. 
When using the adenylate energy charge parameter (ECP) as an indicator of the 
maintenance of adenine nucleotide levels during quenching, some techniques 
have been shown to be too slow, as well as resulting in leakage of many cellular 
metabolites (8). ESI-TOF-MS direct injection methods enable a quenching 
methodology to be employed that results in no metabolite loss, through the 
freezing of whole cell pellets in liquid nitrogen (-196¡C). However in the case of 
bacterial cells like C. jejuni this does require a short centrifugation step (1). 
Although some metabolic changes will inevitably occur during such processing, for 
the particular approach we describe here, where wild-type and mutant strains are 
!subjected to the same quenching and extraction conditions, valid comparisons are 
possible. The efficacy of metabolite extraction techniques have been shown to be 
organism specific (8), but many comparative studies have shown cold methanol 
based methodologies to be the most efficient for extracting the broadest range of 
metabolites (8, 9, 10). For this reason a simple cold methanol based extraction 
protocol was adopted in our work, enabling high reproducibility and extraction of 
a broad range of metabolites (1, 11). Below, we provide details of the methods we 
have used to obtain metabolite profiles from C. jejuni strains using DIMS, based on 
our recent publication (1). 
!
2. Materials 
2.1 Growth media 
1. Columbia agar containing 5 % (v/v) lysed horse blood and 10 µg mlÐ1 
amphotericin B and vancomycin (CA-AV) for sub-culturing of strains. 
2. For liquid growth of isogenic mutants use Brain Heart Infusion with 5 % (v/v) 
foetal calf serum (BHI-FCS). No selective antibiotics are used so as not to affect 
metabolism (see NOTE 1). 
2.2 Metabolite Extraction 
1. 2 mL polypropylene tubes or other solvent resistant 
type 
2. Liquid nitrogen 
3. HPLC grade methanol:chloroform 1:1 (v/v). (see NOTE 2) 
4. Stainless steel ball bearings (5 mm diameter). (see NOTE 3) 
5. Ultra-high purity (UHP) water. 
!
!2.3 Equipment 
1. A MACS cabinet (Don Whitley Scientific, Shipley, UK) or other micro- aerobic 
incubator, to maintain micro-aerobic growth conditions [we routinely use 10 % 
(v/v) O2, 5 % (v/v) CO2 and 85 % (v/v) N2]. 
2. A temperature controlled microcentrifuge. 
3. A cell disruptor/homogenizer. 
4. A Liquid chromatography (LC) electrospray ionization (EI) time-of-flight (TOF) 
spectrometer (such as a LCT Spectrometer, Waters Ltd, Manchester, UK) with 
an automated Waters 2695 Separations Module combining a high 
performance liquid chromatography (HPLC) pump and autosampler (Waters, 
Hemel Hempstead, UK) with a LocksprayTM interface. 
 
3. Methods 
Throughout all stages it is important to record as much metadata as possible 
regarding differences in sample preparation (i.e different days of extraction, 
different media batches) as this will be used in the final multifactorial analysis to 
look for the influence of methodological variables. The effects of this can be 
minimised by ensuring as much randomising of processing where possible. 
 
3.1 Preparation and sampling of wild-type parent and isogenic mutant strain 
cultures. 
Assume all growth conditions are at 37¡C and under micro-aerobic conditions 
unless otherwise stated. Good aseptic technique must be maintained while 
working with cultures. 
1. Maintain a culture streaked to single colonies on CA-AV plus selective 
!antibiotics. Use a colony to inoculate a 5 mL BHI-FCS starter culture in 25 mL 
conical flasks and grow for 16 hours (until stationary phase), shaking at 180 
rpm. Ensure a minimum of 5 replicates for each strain to be analysed. 
2. Spin down starter cultures (6,000 x g, room temperature ~22¡C) and re-
suspend in 1 mL BHI-FCS. Use to inoculate 25 mL cultures of BHI-FCS in 250 
mL conical flasks to a starting OD600 of 0.1. 
3. Grow cultures under micro-aerobic conditions with adequate shaking until 
they are at the required growth phase for sampling (eg, mid log phase or 
stationary). This can be checked by taking the OD600 of the culture and 
comparing to a known growth curve for the strain being sampled (see NOTE 
4).  
4. Using the OD600, calculate the volume required to take a standardised cell 
density for sampling. For example, sample the equivalent of 1 mL at 
OD600 1.00 for all samples (in this instance a sample measuring OD600 1.12 
would require 893 µL for sampling). 
5. Take the calculated volume and quickly place in a 2 mL polypropylene 
microfuge tube. Spin down the sample in a bench microfuge (14,000 x g, 1 
minute, room temperature) and quickly aspirate off all of the liquid media before 
flash freezing the pellet in liquid nitrogen. During this stage it is important to be 
set up so processing time is minimised as much as possible (see NOTE 5). 
6. Pellets can and must be stored at -80 ¡C prior to metabolite extraction. 
!
3.2 Metabolite extraction 
Unless otherwise stated samples, tubes and solvents are kept on ice at all times. 
1. Remove samples from the -80¡C freezer and place the samples in an ice-
!bucket, open lids and quickly add one pre-chilled 5 mm stainless steel ball-
bearing (see NOTE 3). 
2. Add 1 mL of ice-cold HPLC Grade methanol:chloroform 1:1 (v/v) (stored at -
20¡C overnight prior to extraction) to each tube. 
3. Briefly vortex each tube to homogenise the pellet. 
4. Place tubes at -80¡C for 1 hour. 
5. Remove the samples from the -80¡C freezer and place into a cell disruptor at 
4¡C for 1 minute. 
6. Return samples to -80 ¡C for 1 hour. 
7. Remove the samples from -80¡C and briefly vortex. 
8. Transfer the sample, minus the steel ball bearing, to a new pre-cooled 2 mL 
polypropylene tube. 
9. Add 400 µL of ice-cold UHP water to the sample and briefly vortex before 
centrifugation (4,000 x g, 1 minute, 4¡C). 
10. Transfer the upper aqueous phase to a new 1.5 mL polypropylene tube. 
11. Repeat step 9 before removing the upper aqueous phase and combining with 
the previous extraction. 
12. Store both the lower non-polar (chloroform) phase and upper polar 
(methanol/water aqueous) phase at -80¡C for the subsequent analysis below. 
The analysis method below can be used on either phases.  
!
3.3 Mass-spectrometry based quantification of metabolites 
We previously performed ESI-TOF- MS on an LCT spectrometer operating with 
3.6 GHz time to digital conversion under the control of a MassLynx data system 
(version 4) running on Windows NT on an IBM compatible PC. The mass 
!spectrometer was operated at a resolution of 4000 (FWHM) at mass 200 m/z in 
positive and negative ion modes at a capillary voltage of 2800 V (positive) and 
2500 V (negative), extraction cone at 3 V and sample cone at 20 V with a 
rangefinder lens voltage of 75 V chosen for detection of masses from 50Ð800 
Da. Source temperature was 110¡C and desolvation temperature was 120¡C. 
Flow rates were 100 L/h for nebulisation and 400 L/h
 for desolvation (see NOTE 
6 and 1, 11, 12 for further details). 
 
1. Take the solvent phase from the -80¡C and thaw on ice. 
2. Samples may be loaded by one of two methods: Either using a syringe pump  
at a flow rate of 20 µL/min, or with an automated Waters 2695 Separations 
Module combining a HPLC pump and an autosampler  with an inject volume of 
100 µL at a flow rate of 50 µL /min. (see NOTE 7). 
3. A LocksprayTM interface should be used to give an external standard and 
allow automated correction of mass measurements (5 ng/µL sulphadimethoxine 
gives a lockmass of 309.0653 or 311.0814 for negative and positive 
ionisation modes respectively). Samples can be run in positive or negative 
ionisation mode as described above (see NOTE 8). Run three technical 
replicates for each sample. Spectra should be collected in centroid mode at a 
rate of one spectrum s
-1 
(0.95 s scan time, 0.05 s interscan delay) with 180 
spectra summed over a 3-minute period before being exported from the 
MassLynx data system as text file peak lists (accurate mass to 4 decimal 
places vs. ion count) without background subtraction or smoothing. 
4. Import text files into Microsoft Excel where the accurate masses of three 
replicate analyses of each sample can be compared. 
!5. The accepted range proposed to give the maximum number of peaks with 
minimum false positives was proposed by Overy et al. (11) to be defined best by 
plotting the acceptable mass variance as a linear function of the m/z values. 
The same equations were used in our work: positive mode, y <0.00003x + 
0.0033; for negative mode y <0.00003x + 0.044 where y is the standard 
deviation of the three masses and x is the mean of the three masses. Microsoft 
Excel spreadsheets should be arranged to automate this process and those 
masses found to have a y value within acceptable limits can then have their 
mean accurate mass and mean response (as % total ion count in order to 
minimize sample-sample variation and normalize data sets) exported to a 
separate table. (see NOTE 9). 
!
3.4 Data Analysis 
At this stage each sample should have a list of mean accurate mass and 
mean response as % total ion count. This can undergo various forms of analysis 
and the bioinformatics tools available are in constant development. Here is a brief 
description of two forms of analysis performed by Howlett et al. (1). 
!
1. Principal Component Analysis (PCA) 
PCA is a multivariate data analysis technique that can be used to simplify the 
complexity of the dataset, enabling visualisation of patterns between samples. In 
the case of analysing isogenic mutants it is used to visualise if the metabolome is 
altered such that it can be differentiated from the parent or wild type strain. It is 
important to also include metadata in any analysis to ensure strains are not 
separating due to processing variables, such as the day of extraction or the media 
batch used. Detected masses are used as observations across the strains, 
!treated as variables. Various commercial software packages are available to 
perform PCA (SPSS, IBM Corp¨ or SIMCA-P, Umetrics¨) but an increasing 
number of excellent free online packages can be used such as Metaboanalyst 
http://www.metaboanalyst.ca/ (13). These software packages will accept data 
produced in a similar format and enable the complexity of the data to be broken 
down into a series of orthogonal variables termed principal components. As well as 
analysing strain separation and the effects of methodological variation, these 
techniques can also be used to detect and remove outliers from future analysis. 
Scatter plots produced through PCA are also useful as a means of detecting 
specific mass/molecular weight bins that may be the cause of the separating 
samples. A large literature is available that gives an in depth description of PCA, 
for example (14, 15). 
!
2. Assigning of putative metabolites 
Mean accurate masses can be assigned putative metabolite identities. This has 
previously been performed through the comparison of monoisotopic masses likely 
to be present in extracts (such as [M+H]+, [M+Na]+ and [M-H]- for positive and 
negative ionisation modes respectively) against a list of over 1900 metabolites 
from an in house database compiled from KEGG (http://www.genome.jp/kegg/), 
Biocyc (http://biocyc.org/), Humancyc (http://humancyc.org/) to an accuracy of 0.2 
Da (1) (see NOTE 10). This was performed automatically using an in house 
produced macro in the Microsoft Excel software package (Prof Mike Burrell, The 
University of Sheffield, UK), however other online resources such as METLIN 
(https://metlin.scripps.edu/) and XCMS (https://xcmsonline.scripps.edu/) can also 
perform similar functions. More information on this process can be found in Davey 
!2011 (16). Following the allocation of putative metabolites, relevant statistical 
analysis can be performed to highlight changes of interest. In order to reduce the 
number of false positive results, Benjamini-Hockberg or Bonferroni corrected 
significance levels should be used to isolate the most significant metabolite 
differences between strains and account for possible type 1 errors (17). Tools such 
as the biocyc (www.biocyc.org) omics viewer can then be used to visualise fold 
changes in the metabolites detected across the metabolic pathways of C. jejuni, 
where information on genetic and proteomic information for the pathways are also 
presented (16). 
!
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NOTES 
1. Rich growth medium is used when global analysis of metabolism is performed. 
In these instances it is hoped that as many metabolic pathways are active 
as possible. Also where isogenic mutants may suffer from growth deficiencies 
it is important to optimize growth rate and phase of harvesting to be as close 
to the isogenic parent as possible. In different circumstances, such as in the 
analysis of specific growth conditions or when analysing specific metabolic 
!pathways, a defined growth medium would be preferable. 
2. Mix methanol:chloroform 1:1 (v/v) within a fume hood and cool in a -20 ¡C 
spark-free laboratory freezer prior to use. WARNING: methanol and chloroform 
are highly hazardous chemicals, please read all MSDS and wear appropriate 
personal protective equipment when handling these chemicals throughout the 
procedure. 
3. Ball-bearings must be washed in methanol:chloroform 1:1, autoclaved and 
oven dried. Before use they should be placed in a -20 ¡C freezer overnight. 
4. Where strains may have differing growth rates/dynamics it is important to 
ensure that samples are taken at matched points in their growth cycle. To do 
this you should perform a growth curve prior to analysis, or take the OD600 
throughout to monitor growth. 
5. Our method employs a 1 minute centrifugation before quenching in liquid 
nitrogen completely halts metabolism, enabling retention of the maximum 
number of metabolites. However it is important to note that changes in 
metabolite levels during centrifugation will undoubtedly occur. For this reason 
practice is required to ensure rapid manipulation for maximum reproducibility 
between samples and minimum time spent processing. 
6. Other Direct Injection Mass Spectrometers are also suitable for this technique, 
though MS conditions would have to be slightly altered accordingly. 
Furthermore, similar analyses have been performed using nuclear magnetic 
resonance methods (18) and MALDI-TOF (19), however sample processing 
would have to be altered. 
7. Samples should be analysed in a randomised order to minimise effects of day-
to-day machine variation. Other autosamplers would also be suitable for this 
!step. 
8. Previous analyses have shown that both positive and negative ionisation 
modes are capable of distinguishing between bacterial strains (8). However the 
presence of multiple positive ionisation species compared to the relatively 
simple negative ionisation mode data sets makes negative ionisation mode 
preferable for putative metabolite allocation (1). 
9. This methodology negates the need for a noise threshold and enables true 
low intensity metabolite peaks to be kept. 
10. Lists of predicted C. jejuni specific metabolites can be compiled from 
genome sequence information and exist within e.g the KEGG database, 
however we have found these to be too restrictive, leaving many mass bins 
with no metabolite allocated (1). The use of metabolites lists from multiple 
databases results in some mass bins receiving multiple metabolite identities. 
In these instances knowledge of the likely metabolome is required to decipher 
the most likely identity. Independent confirmation of metabolite identities is 
required to confirm any hypothesis made based on observed changes in 
putatively identified metabolite pools. 
!
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